BIND is developing targeted nanoparticle therapeutics by applying their high throughput combinatorial platform that enables fabrication, screening and optimization of polymeric nanoparticles for a variety of therapeutic indications.

These targeted nanoparticle therapeutics will enable the intracellular delivery of large payloads including small molecules, peptides, proteins and nucleic acids.

Contact Info

325 Vassar Street, 2nd Floor, Cambridge, MA, 02139
Tel: (617) 491-3400

Polaris Lead

Amir Nashat